{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:27:43Z","timestamp":1794508063522,"version":"4.9.1"},"reference-count":214,"publisher":"Springer Science and Business Media LLC","issue":"17","license":[{"start":{"date-parts":[[2009,6,5]],"date-time":"2009-06-05T00:00:00Z","timestamp":1244160000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s00018-009-0053-z","type":"journal-article","created":{"date-parts":[[2009,6,25]],"date-time":"2009-06-25T10:49:42Z","timestamp":1245926982000},"page":"2873-2896","source":"Crossref","is-referenced-by-count":1457,"title":["Nanocarriers\u2019 entry into the cell: relevance to drug delivery"],"prefix":"10.1007","volume":"66","author":[{"given":"Herv\u00e9","family":"Hillaireau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Couvreur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,6,5]]},"reference":[{"key":"53_CR1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1042\/bst0020869","volume":"2","author":"C Black","year":"1974","unstructured":"Black C, Gregoriadis G (1974) Intracellular fate and effect of liposome-entrapped actinomycin-d injected into rats. Biochem Soc Trans 2:869\u2013871","journal-title":"Biochem Soc Trans"},{"key":"53_CR2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0014-5793(77)80717-5","volume":"84","author":"P Couvreur","year":"1977","unstructured":"Couvreur P, Tulkenst P, Roland M, Trouet A, Speiser P (1977) Nanocapsules: a new type of lysosomotropic carrier. FEBS Lett 84:323\u2013326","journal-title":"FEBS Lett"},{"key":"53_CR3","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.addr.2007.05.017","volume":"60","author":"LJ Peek","year":"2008","unstructured":"Peek LJ, Middaugh CR, Berkland C (2008) Nanotechnology in vaccine delivery. Adv Drug Deliv Rev 60:915\u2013928","journal-title":"Adv Drug Deliv Rev"},{"key":"53_CR4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.immunol.17.1.593","volume":"17","author":"A Aderem","year":"1999","unstructured":"Aderem A, Underhill D (1999) Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 17:593\u2013623","journal-title":"Annu Rev Immunol"},{"key":"53_CR5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0962-8924(00)88955-2","volume":"5","author":"M Rabinovitch","year":"1995","unstructured":"Rabinovitch M (1995) Professional and nonprofessional phagocytes\u2014an introduction. Trends Cell Biol 5:85\u201387","journal-title":"Trends Cell Biol"},{"key":"53_CR6","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1016\/j.biomaterials.2006.03.039","volume":"27","author":"A Vonarbourg","year":"2006","unstructured":"Vonarbourg A, Passirani C, Saulnier P, Benoit J (2006) Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials 27:4356\u20134373","journal-title":"Biomaterials"},{"key":"53_CR7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","volume":"307","author":"D Owens","year":"2006","unstructured":"Owens D, Peppas N (2006) Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307:93\u2013102","journal-title":"Int J Pharm"},{"key":"53_CR8","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s00018-008-7578-4","volume":"65","author":"E Groves","year":"2008","unstructured":"Groves E, Dart A, Covarelli V, Caron E (2008) Molecular mechanisms of phagocytic uptake in mammalian cells. Cell Mol Life Sci 65:1957\u20131976","journal-title":"Cell Mol Life Sci"},{"key":"53_CR9","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1182\/blood-2005-09-3808","volume":"107","author":"E Vachon","year":"2006","unstructured":"Vachon E, Martin R, Plumb J, Kwok V, Vandivier R, Glogauer M, Kapus A, Wang X, Chow C, Grinstein S, Downey G (2006) CD44 is a phagocytic receptor. Blood 107:4149\u20134158","journal-title":"Blood"},{"key":"53_CR10","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1126\/science.282.5394.1717","volume":"282","author":"E Caron","year":"1998","unstructured":"Caron E, Hall A (1998) Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science 282:1717\u20131721","journal-title":"Science"},{"key":"53_CR11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0962-8924(00)88956-4","volume":"5","author":"JA Swanson","year":"1995","unstructured":"Swanson JA, Baer SC (1995) Phagocytosis by zippers and triggers. Trends Cell Biol 5:89\u201393","journal-title":"Trends Cell Biol"},{"key":"53_CR12","doi-asserted-by":"crossref","first-page":"9842","DOI":"10.1074\/jbc.273.16.9842","volume":"273","author":"V Claus","year":"1998","unstructured":"Claus V, Jahraus A, Tjelle T, Berg T, Kirschke H, Faulstich H, Griffiths G (1998) Lysosomal enzyme trafficking between phagosomes, endosomes, and lysosomes in J774 macrophages. Enrichment of cathepsin H in early endosomes. J Biol Chem 273:9842\u20139851","journal-title":"J Biol Chem"},{"key":"53_CR13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","volume":"28","author":"JM Anderson","year":"1997","unstructured":"Anderson JM, Shive MS (1997) Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 28:5\u201324","journal-title":"Adv Drug Deliv Rev"},{"key":"53_CR14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0142-9612(84)90002-4","volume":"5","author":"V Lenaerts","year":"1984","unstructured":"Lenaerts V, Couvreur P, Christiaens-Leyh D, Joiris E, Roland M, Rollman B, Speiser P (1984) Degradation of poly (isobutyl cyanoacrylate) nanoparticles. Biomaterials 5:65\u201368","journal-title":"Biomaterials"},{"key":"53_CR15","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/275695a0","volume":"275","author":"G Gregoriadis","year":"1978","unstructured":"Gregoriadis G (1978) Liposomes in the therapy of lysosomal storage diseases. Nature 275:695\u2013696","journal-title":"Nature"},{"key":"53_CR16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0378-5173(83)90166-7","volume":"15","author":"L Grislain","year":"1983","unstructured":"Grislain L, Couvreur P, Lenaerts V, Roland M, Deprezdecampeneere D, Speiser P (1983) Pharmacokinetics and distribution of a biodegradable drug-carrier. Int J Pharm 15:335\u2013345","journal-title":"Int J Pharm"},{"key":"53_CR17","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0955-0674(03)00083-8","volume":"15","author":"M Desjardins","year":"2003","unstructured":"Desjardins M, Griffiths G (2003) Phagocytosis: latex leads the way. Curr Opin Cell Biol 15:498\u2013503","journal-title":"Curr Opin Cell Biol"},{"key":"53_CR18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0092-8674(02)00819-X","volume":"110","author":"A Aderem","year":"2002","unstructured":"Aderem A (2002) How to eat something bigger than your head. Cell 110:5\u20138","journal-title":"Cell"},{"key":"53_CR19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1083\/jcb.34.1.219","volume":"34","author":"ED Korn","year":"1967","unstructured":"Korn ED, Weisman RA (1967) Phagocytosis of latex beads by Acanthamoeba. II. Electron microscopic study of the initial events. J Cell Biol 34:219\u2013227","journal-title":"J Cell Biol"},{"key":"53_CR20","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1023\/A:1015852732512","volume":"9","author":"V Sch\u00e4fer","year":"1992","unstructured":"Sch\u00e4fer V, von Briesen H, Andreesen R, Steffan A, Royer C, Tr\u00f6ster S, Kreuter J, R\u00fcbsamen-Waigmann H (1992) Phagocytosis of nanoparticles by human immunodeficiency virus (HlV)-infected macrophages: a possibility for antiviral drug targeting. Pharm Res 9:541\u2013546","journal-title":"Pharm Res"},{"key":"53_CR21","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0142-9612(88)90033-6","volume":"9","author":"Y Tabata","year":"1988","unstructured":"Tabata Y, Ikada Y (1988) Effect of the size and surface-charge of polymer microspheres on their phagocytosis by macrophage. Biomaterials 9:356\u2013362","journal-title":"Biomaterials"},{"key":"53_CR22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0163-7827(03)00033-X","volume":"42","author":"SM Moghimi","year":"2003","unstructured":"Moghimi SM, Szebeni J (2003) Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res 42:463\u2013478","journal-title":"Prog Lipid Res"},{"key":"53_CR23","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0005-2736(85)90217-2","volume":"820","author":"TD Heath","year":"1985","unstructured":"Heath TD, Lopez NG, Papahadjopoulos D (1985) The effects of liposome size and surface charge on liposome-mediated delivery of methotrexate-gamma-aspartate to cells in vitro. Biochim Biophys Acta 820:74\u201384","journal-title":"Biochim Biophys Acta"},{"key":"53_CR24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0005-2736(91)90268-D","volume":"1061","author":"TM Allen","year":"1991","unstructured":"Allen TM, Austin GA, Chonn A, Lin L, Lee KC (1991) Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size. Biochim Biophys Acta Biomembranes 1061:56\u201364","journal-title":"Biochim Biophys Acta Biomembranes"},{"key":"53_CR25","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jbm.a.30711","volume":"78","author":"A Vonarbourg","year":"2006","unstructured":"Vonarbourg A, Passirani C, Saulnier P, Simard P, Leroux JC, Benoit JP (2006) Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake. J Biomed Mater Res A 78:620\u2013628","journal-title":"J Biomed Mater Res A"},{"key":"53_CR26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0001-8686(95)00241-H","volume":"57","author":"PM Claesson","year":"1995","unstructured":"Claesson PM, Blomberg E, Fr\u00f6berg JC, Nylander T, Arnebrant T (1995) Protein interactions at solid surfaces. Adv Colloid Interface Sci 57:161\u2013227","journal-title":"Adv Colloid Interface Sci"},{"key":"53_CR27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0005-2736(94)90231-3","volume":"1191","author":"DV Devine","year":"1994","unstructured":"Devine DV, Wong K, Serrano K, Chonn A, Cullis PR (1994) Liposome-complement interactions in rat serum: implications for liposome survival studies. Biochim Biophys Acta 1191:43\u201351","journal-title":"Biochim Biophys Acta"},{"key":"53_CR28","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.4049\/jimmunol.146.12.4234","volume":"146","author":"A Chonn","year":"1991","unstructured":"Chonn A, Cullis PR, Devine DV (1991) The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. J Immunol 146:4234\u20134241","journal-title":"J Immunol"},{"key":"53_CR29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0167-4889(93)90137-E","volume":"1179","author":"SM Moghimi","year":"1993","unstructured":"Moghimi SM, Muir IS, Illum L, Davis SS, Kolb-Bachofen V (1993) Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. Biochim Biophys Acta 1179:157\u2013165","journal-title":"Biochim Biophys Acta"},{"key":"53_CR30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(97)00133-6","volume":"32","author":"G Scherphof","year":"1998","unstructured":"Scherphof G, Kamps J (1998) Receptor versus non-receptor mediated clearance of liposomes. Adv Drug Deliver Rev 32:81\u201397","journal-title":"Adv Drug Deliver Rev"},{"key":"53_CR31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0939-6411(98)00038-1","volume":"46","author":"M Roser","year":"1998","unstructured":"Roser M, Fischer D, Kissel T (1998) Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. Eur J Pharm Biopharm 46:255\u2013263","journal-title":"Eur J Pharm Biopharm"},{"key":"53_CR32","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0142-9612(92)90177-P","volume":"13","author":"ME Norman","year":"1992","unstructured":"Norman ME, Williams P, Illum L (1992) Human serum albumin as a probe for surface conditioning (opsonization) of block copolymer-coated microspheres. Biomaterials 13:841\u2013849","journal-title":"Biomaterials"},{"key":"53_CR33","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0024-3205(95)00321-V","volume":"57","author":"J Leroux","year":"1995","unstructured":"Leroux J, De Jaeghere F, Anner B, Doelker E, Gurny R (1995) An investigation on the role of plasma and serum opsonins on the evternalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytes. Life Sci 57:695\u2013703","journal-title":"Life Sci"},{"key":"53_CR34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijpharm.2007.07.038","volume":"349","author":"F Esmaeili","year":"2008","unstructured":"Esmaeili F, Ghahremani MH, Esmaeili B, Khoshayand MR, Atyabi F, Dinarvand R (2008) PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution. Int J Pharm 349:249\u2013255","journal-title":"Int J Pharm"},{"key":"53_CR35","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s11095-006-0069-0","volume":"23","author":"I Bertholon","year":"2006","unstructured":"Bertholon I, Vauthier C, Labarre D (2006) Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: influences of surface morphology, length, and type of polysaccharide. Pharm Res 23:1313\u20131323","journal-title":"Pharm Res"},{"key":"53_CR36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0021-9797(91)90043-8","volume":"142","author":"S Jeon","year":"1991","unstructured":"Jeon S, Lee J, Andrade J, De Gennes P (1991) Protein-surface interactions in the presence of polyethylene oxide: I. Simplified theory. J Colloid Interface Sci 142:149\u2013158","journal-title":"J Colloid Interface Sci"},{"key":"53_CR37","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF01480835","volume":"258","author":"CJ Oss van","year":"1980","unstructured":"van Oss CJ, Absolom DR, Neumann AW (1980) The \u201chydrophobic effect\u201d: essentially a van der Waals interaction. Colloid Polym Sci 258:424\u2013427","journal-title":"Colloid Polym Sci"},{"key":"53_CR38","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1126\/science.8128245","volume":"263","author":"R Gref","year":"1994","unstructured":"Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R (1994) Biodegradable long-circulating polymeric nanospheres. Science 263:1600\u20131603","journal-title":"Science"},{"key":"53_CR39","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1023\/A:1011973625803","volume":"15","author":"MT Peracchia","year":"1998","unstructured":"Peracchia MT, Vauthier C, Desma\u00eble D, Gulik A, Dedieu JC, Demoy M, d\u2019Angelo J, Couvreur P (1998) Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer. Pharm Res 15:550\u2013556","journal-title":"Pharm Res"},{"key":"53_CR40","first-page":"1693","volume":"50","author":"M Yokoyama","year":"1990","unstructured":"Yokoyama M, Miyauchi M, Yamada N, Okano T, Sakurai Y, Kataoka K, Inoue S (1990) Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res 50:1693\u20131700","journal-title":"Cancer Res"},{"key":"53_CR41","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s11095-006-0284-8","volume":"23","author":"P Couvreur","year":"2006","unstructured":"Couvreur P, Vauthier C (2006) Nanotechnology: intelligent design to treat complex disease. Pharm Res 23:1417\u20131450","journal-title":"Pharm Res"},{"key":"53_CR42","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ejpb.2004.02.016","volume":"58","author":"C Lemarchand","year":"2004","unstructured":"Lemarchand C, Gref R, Couvreur P (2004) Polysaccharide-decorated nanoparticles. Eur J Pharm Biopharm 58:327\u2013341","journal-title":"Eur J Pharm Biopharm"},{"key":"53_CR43","first-page":"487","volume":"41","author":"A Raz","year":"1981","unstructured":"Raz A, Bucana C, Fogler WE, Poste G, Fidler IJ (1981) Biochemical, morphological, and ultrastructural studies on the uptake of liposomes by murine macrophages. Cancer Res 41:487\u2013494","journal-title":"Cancer Res"},{"key":"53_CR44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0005-2736(84)90521-2","volume":"772","author":"R Schwendener","year":"1984","unstructured":"Schwendener R, Lagocki P, Rahman Y (1984) The effects of charge and size on the interaction of unilamellar liposomes with macrophages. Biochim Biophys Acta Biomembranes 772:93\u2013101","journal-title":"Biochim Biophys Acta Biomembranes"},{"key":"53_CR45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0005-2736(92)90086-2","volume":"1103","author":"K Lee","year":"1992","unstructured":"Lee K, Hong K, Papahadjopoulos D (1992) Recognition of liposomes by cells: in vitro binding and endocytosis mediated by specific lipid headgroups and surface charge density. Biochim Biophys Acta Biomembranes 1103:185\u2013197","journal-title":"Biochim Biophys Acta Biomembranes"},{"key":"53_CR46","doi-asserted-by":"crossref","first-page":"16221","DOI":"10.1074\/jbc.270.27.16221","volume":"270","author":"A Rigotti","year":"1995","unstructured":"Rigotti A, Acton SL, Krieger M (1995) The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J Biol Chem 270:16221\u201316224","journal-title":"J Biol Chem"},{"key":"53_CR47","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0167-4889(88)90184-X","volume":"971","author":"JT Derksen","year":"1988","unstructured":"Derksen JT, Morselt HW, Scherphof GL (1988) Uptake and processing of immunoglobulin-coated liposomes by subpopulations of rat liver macrophages. Biochim Biophys Acta 971:127\u2013136","journal-title":"Biochim Biophys Acta"},{"key":"53_CR48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.2042-7158.1993.tb03678.x","volume":"45","author":"GV Betageri","year":"1993","unstructured":"Betageri GV, Black CD, Szebeni J, Wahl LM, Weinstein JN (1993) Fc-receptor-mediated targeting of antibody-bearing liposomes containing dideoxycytidine triphosphate to human monocyte\/macrophages. J Pharm Pharmacol 45:48\u201353","journal-title":"J Pharm Pharmacol"},{"key":"53_CR49","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/bbrc.1994.1455","volume":"200","author":"L Kole","year":"1994","unstructured":"Kole L, Sarkar K, Mahato SB, Das PK (1994) Neoglycoprotein conjugated liposomes as macrophage specific drug carrier in the therapy of leishmaniasis. Biochem Biophys Res Commun 200:351\u2013358","journal-title":"Biochem Biophys Res Commun"},{"key":"53_CR50","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1172\/JCI119160","volume":"99","author":"B Yu","year":"1997","unstructured":"Yu B, Hailman E, Wright SD (1997) Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. J Clin Invest 99:315\u2013324","journal-title":"J Clin Invest"},{"key":"53_CR51","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1242\/jcs.115.4.849","volume":"115","author":"KA Beningo","year":"2002","unstructured":"Beningo KA, Wang Y (2002) Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target. J Cell Sci 115:849\u2013856","journal-title":"J Cell Sci"},{"key":"53_CR52","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1021\/bm050260e","volume":"6","author":"X Sun","year":"2005","unstructured":"Sun X, Rossin R, Turner JL, Becker ML, Joralemon MJ, Welch MJ, Wooley KL (2005) An assessment of the effects of shell cross-linked nanoparticle size, core composition, and surface PEGylation on in vivo biodistribution. Biomacromolecules 6:2541\u20132554","journal-title":"Biomacromolecules"},{"key":"53_CR53","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0169-409X(01)00104-1","volume":"47","author":"LSS Guo","year":"2001","unstructured":"Guo LSS (2001) Amphotericin B colloidal dispersion: an improved antifungal therapy. Adv Drug Deliv Rev 47:149\u2013163","journal-title":"Adv Drug Deliv Rev"},{"key":"53_CR54","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1128\/AAC.47.12.3774-3779.2003","volume":"47","author":"M Larabi","year":"2003","unstructured":"Larabi M, Yardley V, Loiseau PM, Appel M, Legrand P, Gulik A, Bories C, Croft SL, Barratt G (2003) Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin B. Antimicrob Agents Chemother 47:3774\u20133779","journal-title":"Antimicrob Agents Chemother"},{"key":"53_CR55","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1359-0294(00)00020-0","volume":"4","author":"CJ Drummond","year":"1999","unstructured":"Drummond CJ, Fong C (1999) Surfactant self-assembly objects as novel drug delivery vehicles. Curr Opin Colloid Interface Sci 4:449\u2013456","journal-title":"Curr Opin Colloid Interface Sci"},{"key":"53_CR56","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1073\/pnas.0600997103","volume":"103","author":"JA Champion","year":"2006","unstructured":"Champion JA, Mitragotri S (2006) Role of target geometry in phagocytosis. Proc Natl Acad Sci USA 103:4930\u20134934","journal-title":"Proc Natl Acad Sci USA"},{"key":"53_CR57","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/jps.2600730730","volume":"73","author":"V Lenaerts","year":"1984","unstructured":"Lenaerts V, Nagelkerke JF, Van Berkel TJ, Couvreur P, Grislain L, Roland M, Speiser P (1984) In vivo uptake of polyisobutyl cyanoacrylate nanoparticles by rat liver Kupffer, endothelial, and parenchymal cells. J Pharm Sci 73:980\u2013982","journal-title":"J Pharm Sci"},{"key":"53_CR58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/sct.1989.5.1","volume":"5","author":"N Chiannilkulchai","year":"1989","unstructured":"Chiannilkulchai N, Driouich Z, Benoit JP, Parodi AL, Couvreur P (1989) Doxorubicin-loaded nanoparticles: increased efficiency in murine hepatic metastases. Sel Cancer Ther 5:1\u201311","journal-title":"Sel Cancer Ther"},{"key":"53_CR59","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0006-2952(92)90443-M","volume":"44","author":"C Cuvier","year":"1992","unstructured":"Cuvier C, Roblot-Treupel L, Millot JM, Lizard G, Chevillard S, Manfait M, Couvreur P, Poupon MF (1992) Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance. Biochem Pharmacol 44:509\u2013517","journal-title":"Biochem Pharmacol"},{"key":"53_CR60","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF02897257","volume":"26","author":"N Chiannilkulchai","year":"1990","unstructured":"Chiannilkulchai N, Ammoury N, Caillou B, Devissaguet J, Couvreur P (1990) Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice. Cancer Chemother Pharmacol 26:122\u2013126","journal-title":"Cancer Chemother Pharmacol"},{"key":"53_CR61","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/BF00686509","volume":"33","author":"A Colin de Verdi\u00e8re","year":"1994","unstructured":"Colin de Verdi\u00e8re A, Dubernet C, Nemati F, Poupon MF, Puisieux F, Couvreur P (1994) Uptake of doxorubicin from loaded nanoparticles in multidrug-resistant leukemic murine cells. Cancer Chemother Pharmacol 33:504\u2013508","journal-title":"Cancer Chemother Pharmacol"},{"key":"53_CR62","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/bjc.1997.362","volume":"76","author":"AC Verdi\u00e8re de","year":"1997","unstructured":"de Verdi\u00e8re AC, Dubernet C, N\u00e9mati F, Soma E, Appel M, Fert\u00e9 J, Bernard S, Puisieux F, Couvreur P (1997) Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action. Br J Cancer 76:198\u2013205","journal-title":"Br J Cancer"},{"key":"53_CR63","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF00877245","volume":"10","author":"J Kattan","year":"1992","unstructured":"Kattan J, Droz JP, Couvreur P, Marino JP, Boutan-Laroze A, Rougier P, Brault P, Vranckx H, Grognet JM, Morge X (1992) Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles. Invest New Drugs 10:191\u2013199","journal-title":"Invest New Drugs"},{"key":"53_CR64","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/jps.2600791202","volume":"79","author":"S Amselem","year":"1990","unstructured":"Amselem S, Gabizon A, Barenholz Y (1990) Optimization and upscaling of doxorubicin-containing liposomes for clinical use. J Pharm Sci 79:1045\u20131052","journal-title":"J Pharm Sci"},{"key":"53_CR65","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/0277-5379(89)90350-7","volume":"25","author":"A Gabizon","year":"1989","unstructured":"Gabizon A, Peretz T, Sulkes A, Amselem S, Ben-Yosef R, Ben-Baruch N, Catane R, Biran S, Barenholz Y (1989) Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study. Eur J Cancer Clin Oncol 25:1795\u20131803","journal-title":"Eur J Cancer Clin Oncol"},{"key":"53_CR66","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1002\/jps.21179","volume":"97","author":"JJ Torrado","year":"2008","unstructured":"Torrado JJ, Espada R, Ballesteros MP, Torrado-Santiago S (2008) Amphotericin B formulations and drug targeting. J Pharm Sci 97:2405\u20132425","journal-title":"J Pharm Sci"},{"issue":"Suppl 1","key":"53_CR67","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jac\/49.suppl_1.21","volume":"49","author":"J Adler-Moore","year":"2002","unstructured":"Adler-Moore J, Proffitt RT (2002) AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience. J Antimicrob Chemother 49(Suppl 1):21\u201330","journal-title":"J Antimicrob Chemother"},{"key":"53_CR68","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1023\/A:1015807706530","volume":"9","author":"R Gaspar","year":"1992","unstructured":"Gaspar R, Pr\u00e9at V, Opperdoes FR, Roland M (1992) Macrophage activation by polymeric nanoparticles of polyalkylcyanoacrylates: activity against intracellular Leishmania donovani associated with hydrogen peroxide production. Pharm Res 9:782\u2013787","journal-title":"Pharm Res"},{"key":"53_CR69","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/10611860500046732","volume":"13","author":"R Tyagi","year":"2005","unstructured":"Tyagi R, Lala S, Verma AK, Nandy AK, Mahato SB, Maitra A, Basu MK (2005) Targeted delivery of arjunglucoside I using surface hydrophilic and hydrophobic nanocarriers to combat experimental leishmaniasis. J Drug Target 13:161\u2013171","journal-title":"J Drug Target"},{"key":"53_CR70","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0076-6879(05)91015-X","volume":"391","author":"II Salem","year":"2005","unstructured":"Salem II, Flasher DL, D\u00fczg\u00fcne\u015f N (2005) Liposome-encapsulated antibiotics. Methods Enzymol 391:261\u2013291","journal-title":"Methods Enzymol"},{"key":"53_CR71","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1023\/A:1011925132473","volume":"15","author":"RM Fielding","year":"1998","unstructured":"Fielding RM, Lewis RO, Moon-McDermott L (1998) Altered tissue distribution and elimination of amikacin encapsulated in unilamellar, low-clearance liposomes (MiKasome). Pharm Res 15:1775\u20131781","journal-title":"Pharm Res"},{"key":"53_CR72","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/jac\/48.6.877","volume":"48","author":"PR Donald","year":"2001","unstructured":"Donald PR, Sirgel FA, Venter A, Smit E, Parkin DP, Van de Wal BW, Mitchison DA (2001) The early bactericidal activity of a low-clearance liposomal amikacin in pulmonary tuberculosis. J Antimicrob Chemother 48:877\u2013880","journal-title":"J Antimicrob Chemother"},{"key":"53_CR73","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1128\/AAC.35.4.770","volume":"35","author":"E Fattal","year":"1991","unstructured":"Fattal E, Rojas J, Youssef M, Couvreur P, Andremont A (1991) Liposome-entrapped ampicillin in the treatment of experimental murine listeriosis and salmonellosis. Antimicrob Agents Chemother 35:770\u2013772","journal-title":"Antimicrob Agents Chemother"},{"key":"53_CR74","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1128\/AAC.32.8.1204","volume":"32","author":"M Youssef","year":"1988","unstructured":"Youssef M, Fattal E, Alonso MJ, Roblot-Treupel L, Sauzi\u00e8res J, Tancr\u00e8de C, Omn\u00e8s A, Couvreur P, Andremont A (1988) Effectiveness of nanoparticle-bound ampicillin in the treatment of Listeria monocytogenes infection in athymic nude mice. Antimicrob Agents Chemother 32:1204\u20131207","journal-title":"Antimicrob Agents Chemother"},{"key":"53_CR75","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1128\/AAC.40.6.1467","volume":"40","author":"AR Bender","year":"1996","unstructured":"Bender AR, von Briesen H, Kreuter J, Duncan IB, R\u00fcbsamen-Waigmann H (1996) Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes\/macrophages in vitro. Antimicrob Agents Chemother 40:1467\u20131471","journal-title":"Antimicrob Agents Chemother"},{"key":"53_CR76","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0168-3659(97)00105-3","volume":"50","author":"R L\u00f6benberg","year":"1998","unstructured":"L\u00f6benberg R, Araujo L, von Briesen H, Rodgers E, Kreuter J (1998) Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats. J Control Release 50:21\u201330","journal-title":"J Control Release"},{"key":"53_CR77","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1023\/A:1011050209986","volume":"18","author":"A Dembri","year":"2001","unstructured":"Dembri A, Montisci MJ, Gantier JC, Chacun H, Ponchel G (2001) Targeting of 3\u2032-azido 3\u2032-deoxythymidine (AZT)-loaded poly(isohexylcyanoacrylate) nanospheres to the gastrointestinal mucosa and associated lymphoid tissues. Pharm Res 18:467\u2013473","journal-title":"Pharm Res"},{"key":"53_CR78","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jconrel.2006.09.016","volume":"116","author":"H Hillaireau","year":"2006","unstructured":"Hillaireau H, Le Doan T, Appel M, Couvreur P (2006) Hybrid polymer nanocapsules enhance in vitro delivery of azidothymidine-triphosphate to macrophages. J Control Release 116:346\u2013352","journal-title":"J Control Release"},{"key":"53_CR79","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1152\/physrev.1997.77.3.759","volume":"77","author":"S Mukherjee","year":"1997","unstructured":"Mukherjee S, Ghosh RN, Maxfield FR (1997) Endocytosis. Physiol Rev 77:759\u2013803","journal-title":"Physiol Rev"},{"key":"53_CR80","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.cell.2006.02.007","volume":"124","author":"M Marsh","year":"2006","unstructured":"Marsh M, Helenius A (2006) Virus entry: open sesame. Cell 124:729\u2013740","journal-title":"Cell"},{"key":"53_CR81","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.addr.2007.06.008","volume":"59","author":"LM Bareford","year":"2007","unstructured":"Bareford LM, Swaan PW (2007) Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev 59:748\u2013758","journal-title":"Adv Drug Deliv Rev"},{"key":"53_CR82","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1083\/jcb.42.1.202","volume":"42","author":"T Kanaseki","year":"1969","unstructured":"Kanaseki T, Kadota K (1969) The \u201cvesicle in a basket\u201d. A morphological study of the coated vesicle isolated from the nerve endings of the guinea pig brain, with special reference to the mechanism of membrane movements. J Cell Biol 42:202\u2013220","journal-title":"J Cell Biol"},{"key":"53_CR83","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nature01451","volume":"422","author":"SD Conner","year":"2003","unstructured":"Conner SD, Schmid SL (2003) Regulated portals of entry into the cell. Nature 422:37\u201344","journal-title":"Nature"},{"key":"53_CR84","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0955-0674(94)90075-2","volume":"6","author":"K Matter","year":"1994","unstructured":"Matter K, Mellman I (1994) Mechanisms of cell polarity: sorting and transport in epithelial cells. Curr Opin Cell Biol 6:545\u2013554","journal-title":"Curr Opin Cell Biol"},{"key":"53_CR85","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s11095-007-9379-0","volume":"24","author":"A Jones","year":"2007","unstructured":"Jones A, Shusta E (2007) Blood\u2013brain barrier transport of therapeutics via receptor-mediation. Pharm Res 24:1759\u20131771","journal-title":"Pharm Res"},{"key":"53_CR86","first-page":"28","volume":"73","author":"PE Str\u00f8mhaug","year":"1997","unstructured":"Str\u00f8mhaug PE, Berg TO, Gj\u00f8en T, Seglen PO (1997) Differences between fluid-phase endocytosis (pinocytosis) and receptor-mediated endocytosis in isolated rat hepatocytes. Eur J Cell Biol 73:28\u201339","journal-title":"Eur J Cell Biol"},{"key":"53_CR87","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrm2216","volume":"8","author":"S Mayor","year":"2007","unstructured":"Mayor S, Pagano RE (2007) Pathways of clathrin-independent endocytosis. Nat Rev Mol Cell Biol 8:603\u2013612","journal-title":"Nat Rev Mol Cell Biol"},{"key":"53_CR88","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0962-8924(00)89101-1","volume":"5","author":"JA Swanson","year":"1995","unstructured":"Swanson JA, Watts C (1995) Macropinocytosis. Trends Cell Biol 5:424\u2013428","journal-title":"Trends Cell Biol"},{"key":"53_CR89","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1242\/jcs.102.4.867","volume":"102","author":"EL Racoosin","year":"1992","unstructured":"Racoosin EL, Swanson JA (1992) M-CSF-induced macropinocytosis increases solute endocytosis but not receptor-mediated endocytosis in mouse macrophages. J Cell Sci 102:867\u2013880","journal-title":"J Cell Sci"},{"key":"53_CR90","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0168-3659(00)00358-8","volume":"71","author":"W Zauner","year":"2001","unstructured":"Zauner W, Farrow NA, Haines AMR (2001) In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density. J Control Release 71:39\u201351","journal-title":"J Control Release"},{"key":"53_CR91","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1023\/A:1012126301290","volume":"14","author":"MP Desai","year":"1997","unstructured":"Desai MP, Labhasetwar V, Walter E, Levy RJ, Amidon GL (1997) The mechanism of uptake of biodegradable microparticles in caco-2 cells is size dependent. Pharm Res 14:1568\u20131573","journal-title":"Pharm Res"},{"key":"53_CR92","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1023\/A:1016085108889","volume":"13","author":"MP Desai","year":"1996","unstructured":"Desai MP, Labhasetwar V, Amidon GL, Levy RJ (1996) Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res 13:1838\u20131845","journal-title":"Pharm Res"},{"key":"53_CR93","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1023\/B:PHAM.0000022411.47059.76","volume":"21","author":"M Qaddoumi","year":"2004","unstructured":"Qaddoumi M, Ueda H, Yang J, Davda J, Labhasetwar V, Lee V (2004) The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers. Pharm Res 21:641\u2013648","journal-title":"Pharm Res"},{"key":"53_CR94","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.2042-7158.1996.tb03911.x","volume":"48","author":"P Calvo","year":"1996","unstructured":"Calvo P, Alonso MJ, Vila-Jato JL, Robinson JR (1996) Improved ocular bioavailability of indomethacin by novel ocular drug carriers. J Pharm Pharmacol 48:1147\u20131152","journal-title":"J Pharm Pharmacol"},{"key":"53_CR95","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1042\/bj20031253","volume":"377","author":"J Rejman","year":"2004","unstructured":"Rejman J, Oberle V, Zuhorn IS, Hoekstra D (2004) Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J 377:159\u2013169","journal-title":"Biochem J"},{"key":"53_CR96","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1016\/j.biomaterials.2007.02.021","volume":"28","author":"SK Lai","year":"2007","unstructured":"Lai SK, Hida K, Man ST, Chen C, Machamer C, Schroer TA, Hanes J (2007) Privileged delivery of polymer nanoparticles to the perinuclear region of live cells via a non-clathrin, non-degradative pathway. Biomaterials 28:2876\u20132884","journal-title":"Biomaterials"},{"key":"53_CR97","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/bm700535p","volume":"9","author":"O Harush-Frenkel","year":"2008","unstructured":"Harush-Frenkel O, Rozentur E, Benita S, Altschuler Y (2008) Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells. Biomacromolecules 9:435\u2013443","journal-title":"Biomacromolecules"},{"key":"53_CR98","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1007\/s11095-005-8175-y","volume":"22","author":"S Mao","year":"2005","unstructured":"Mao S, Germershaus O, Fischer D, Linn T, Schnepf R, Kissel T (2005) Uptake and Transport Of PEG-graft-trimethyl-chitosan copolymer-insulin nanocomplexes by epithelial cells. Pharm Res 22:2058\u20132068","journal-title":"Pharm Res"},{"key":"53_CR99","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1023\/A:1020404615898","volume":"19","author":"M Huang","year":"2002","unstructured":"Huang M, Ma Z, Khor E, Lim L (2002) Uptake of FITC-chitosan nanoparticles by A549 cells. Pharm Res 19:1488\u20131494","journal-title":"Pharm Res"},{"key":"53_CR100","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbrc.2006.11.135","volume":"353","author":"O Harush-Frenkel","year":"2007","unstructured":"Harush-Frenkel O, Debotton N, Benita S, Altschuler Y (2007) Targeting of nanoparticles to the clathrin-mediated endocytic pathway. Biochem Biophys Res Commun 353:26\u201332","journal-title":"Biochem Biophys Res Commun"},{"key":"53_CR101","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1023\/A:1018910922633","volume":"10","author":"C Ropert","year":"1993","unstructured":"Ropert C, Malvy C, Couvreur P (1993) Inhibition of the Friend retrovirus by antisense oligonucleotides encapsulated in liposomes: mechanism of action. Pharm Res 10:1427\u20131433","journal-title":"Pharm Res"},{"key":"53_CR102","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1021\/bi00302a029","volume":"23","author":"H Ellens","year":"1984","unstructured":"Ellens H, Bentz J, Szoka FC (1984) pH-induced destabilization of phosphatidylethanolamine-containing liposomes: role of bilayer contact. Biochemistry 23:1532\u20131538","journal-title":"Biochemistry"},{"key":"53_CR103","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0163-7827(00)00011-4","volume":"39","author":"DC Drummond","year":"2000","unstructured":"Drummond DC, Zignani M, Leroux J (2000) Current status of pH-sensitive liposomes in drug delivery. Prog Lipid Res 39:409\u2013460","journal-title":"Prog Lipid Res"},{"key":"53_CR104","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.addr.2007.06.003","volume":"59","author":"JK Vasir","year":"2007","unstructured":"Vasir JK, Labhasetwar V (2007) Biodegradable nanoparticles for cytosolic delivery of therapeutics. Adv Drug Deliv Rev 59:718\u2013728","journal-title":"Adv Drug Deliv Rev"},{"key":"53_CR105","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0014-5793(85)80210-6","volume":"179","author":"RM Straubinger","year":"1985","unstructured":"Straubinger RM, D\u00fczg\u00fcnes N, Papahadjopoulos D (1985) pH-sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules. FEBS Lett 179:148\u2013154","journal-title":"FEBS Lett"},{"key":"53_CR106","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0006-291X(92)90565-3","volume":"183","author":"C Ropert","year":"1992","unstructured":"Ropert C, Lavignon M, Dubernet C, Couvreur P, Malvy C (1992) Oligonucleotides encapsulated in pH sensitive liposomes are efficient toward Friend retrovirus. Biochem Biophys Res Commun 183:879\u2013885","journal-title":"Biochem Biophys Res Commun"},{"key":"53_CR107","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/0304-4165(86)90197-2","volume":"884","author":"J Connor","year":"1986","unstructured":"Connor J, Norley N, Huang L (1986) Biodistribution of pH-sensitive immunoliposomes. Biochim Biophys Acta 884:474\u2013481","journal-title":"Biochim Biophys Acta"},{"key":"53_CR108","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/S0021-9258(17)41980-6","volume":"269","author":"JH Felgner","year":"1994","unstructured":"Felgner JH, Kumar R, Sridhar CN, Wheeler CJ, Tsai YJ, Border R, Ramsey P, Martin M, Felgner PL (1994) Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem 269:2550\u20132561","journal-title":"J Biol Chem"},{"key":"53_CR109","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v21.i4.10","volume":"21","author":"D Simberg","year":"2004","unstructured":"Simberg D, Weisman S, Talmon Y, Barenholz Y (2004) DOTAP (and other cationic lipids): chemistry, biophysics, and transfection. Crit Rev Ther Drug Carrier Syst 21:257\u2013317","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"53_CR110","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2174\/1566523043345940","volume":"4","author":"B Demeneix","year":"2004","unstructured":"Demeneix B, Hassani Z, Behr J (2004) Towards multifunctional synthetic vectors. Curr Gene Ther 4:445\u2013455","journal-title":"Curr Gene Ther"},{"key":"53_CR111","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1073\/pnas.92.16.7297","volume":"92","author":"O Boussif","year":"1995","unstructured":"Boussif O, Lezoualc\u2019h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 92:7297\u20137301","journal-title":"Proc Natl Acad Sci USA"},{"key":"53_CR112","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2533\/chimia.1997.34","volume":"51","author":"JP Behr","year":"1997","unstructured":"Behr JP (1997) The proton sponge: a trick to enter cells the viruses did not exploit. Chimia 51:34\u201336","journal-title":"Chimia"},{"key":"53_CR113","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/jgm.773","volume":"7","author":"M Neu","year":"2005","unstructured":"Neu M, Fischer D, Kissel T (2005) Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives. J Gene Med 7:992\u20131009","journal-title":"J Gene Med"},{"key":"53_CR114","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1023\/A:1019854327540","volume":"19","author":"I Behrens","year":"2002","unstructured":"Behrens I, Pena AIV, Alonso MJ, Kissel T (2002) Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport. Pharm Res 19:1185\u20131193","journal-title":"Pharm Res"},{"key":"53_CR115","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.biomaterials.2007.01.005","volume":"28","author":"I Bravo-Osuna","year":"2007","unstructured":"Bravo-Osuna I, Vauthier C, Farabollini A, Palmieri GF, Ponchel G (2007) Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles. Biomaterials 28:2233\u20132243","journal-title":"Biomaterials"},{"key":"53_CR116","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0168-3659(01)00486-2","volume":"78","author":"A Vila","year":"2002","unstructured":"Vila A, S\u00e1nchez A, Tob\u00edo M, Calvo P, Alonso MJ (2002) Design of biodegradable particles for protein delivery. J Control Release 78:15\u201324","journal-title":"J Control Release"},{"key":"53_CR117","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0378-5173(97)00083-5","volume":"153","author":"P Calvo","year":"1997","unstructured":"Calvo P, Vila-Jato JL, Alonso MJ (1997) Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. Int J Pharm 153:41\u201350","journal-title":"Int J Pharm"},{"key":"53_CR118","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1124\/jpet.102.039669","volume":"303","author":"I Brigger","year":"2002","unstructured":"Brigger I, Morizet J, Aubert G, Chacun H, Terrier-Lacombe M, Couvreur P, Vassal G (2002) Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting. J Pharmacol Exp Ther 303:928\u2013936","journal-title":"J Pharmacol Exp Ther"},{"key":"53_CR119","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1007\/s00018-005-5094-3","volume":"62","author":"E Garcia-Garcia","year":"2005","unstructured":"Garcia-Garcia E, Gil S, Andrieux K, Desma\u00eble D, Nicolas V, Taran F, Georgin D, Andreux JP, Roux F, Couvreur P (2005) A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles. Cell Mol Life Sci 62:1400\u20131408","journal-title":"Cell Mol Life Sci"},{"key":"53_CR120","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00018-007-6390-x","volume":"64","author":"HR Kim","year":"2007","unstructured":"Kim HR, Gil S, Andrieux K, Nicolas V, Appel M, Chacun H, Desma\u00eble D, Taran F, Georgin D, Couvreur P (2007) Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells. Cell Mol Life Sci 64:356\u2013364","journal-title":"Cell Mol Life Sci"},{"key":"53_CR121","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1021\/bm060711a","volume":"8","author":"HR Kim","year":"2007","unstructured":"Kim HR, Andrieux K, Gil S, Taverna M, Chacun H, Desma\u00eble D, Taran F, Georgin D, Couvreur P (2007) Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis. Biomacromolecules 8:793\u2013799","journal-title":"Biomacromolecules"},{"key":"53_CR122","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0169-409X(00)00122-8","volume":"47","author":"J Kreuter","year":"2001","unstructured":"Kreuter J (2001) Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 47:65\u201381","journal-title":"Adv Drug Deliv Rev"},{"key":"53_CR123","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1023\/A:1018947208597","volume":"16","author":"J Olivier","year":"1999","unstructured":"Olivier J, Fenart L, Chauvet R, Pariat C, Cecchelli R, Couet W (1999) Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity. Pharm Res 16:1836\u20131842","journal-title":"Pharm Res"},{"key":"53_CR124","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1023\/A:1022604120952","volume":"20","author":"J Kreuter","year":"2003","unstructured":"Kreuter J, Ramge P, Petrov V, Hamm S, Gelperina SE, Engelhardt B, Alyautdin R, von Briesen H, Begley DJ (2003) Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles. Pharm Res 20:409\u2013416","journal-title":"Pharm Res"},{"key":"53_CR125","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1021\/bc049853x","volume":"15","author":"ER Gillies","year":"2004","unstructured":"Gillies ER, Goodwin AP, Fr\u00e9chet JMJ (2004) Acetals as pH-sensitive linkages for drug delivery. Bioconjug Chem 15:1254\u20131263","journal-title":"Bioconjug Chem"},{"key":"53_CR126","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1021\/bc049851c","volume":"16","author":"ER Gillies","year":"2005","unstructured":"Gillies ER, Fr\u00e9chet JMJ (2005) pH-Responsive copolymer assemblies for controlled release of doxorubicin. Bioconjug Chem 16:361\u2013368","journal-title":"Bioconjug Chem"},{"key":"53_CR127","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1021\/bc0498166","volume":"16","author":"Y Bae","year":"2005","unstructured":"Bae Y, Nishiyama N, Fukushima S, Koyama H, Yasuhiro M, Kataoka K (2005) Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bioconjug Chem 16:122\u2013130","journal-title":"Bioconjug Chem"},{"key":"53_CR128","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1166\/jnn.2006.443","volume":"6","author":"MD Chavanpatil","year":"2006","unstructured":"Chavanpatil MD, Khdair A, Panyam J (2006) Nanoparticles for cellular drug delivery: mechanisms and factors influencing delivery. J Nanosci Nanotechnol 6:2651\u20132663","journal-title":"J Nanosci Nanotechnol"},{"key":"53_CR129","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/jps.20457","volume":"94","author":"AR Hilgenbrink","year":"2005","unstructured":"Hilgenbrink AR, Low PS (2005) Folate receptor-mediated drug targeting: from therapeutics to diagnostics. J Pharm Sci 94:2135\u20132146","journal-title":"J Pharm Sci"},{"key":"53_CR130","first-page":"3396","volume":"52","author":"SD Weitman","year":"1992","unstructured":"Weitman SD, Lark RH, Coney LR, Fort DW, Frasca V, Zurawski VR, Kamen BA (1992) Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res 52:3396\u20133401","journal-title":"Cancer Res"},{"key":"53_CR131","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1021\/bc0255182","volume":"13","author":"E Dauty","year":"2002","unstructured":"Dauty E, Remy J, Zuber G, Behr J (2002) Intracellular delivery of nanometric DNA particles via the folate receptor. Bioconjug Chem 13:831\u2013839","journal-title":"Bioconjug Chem"},{"key":"53_CR132","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.addr.2004.01.010","volume":"56","author":"S Sabharanjak","year":"2004","unstructured":"Sabharanjak S, Mayor S (2004) Folate receptor endocytosis and trafficking. Adv Drug Deliv Rev 56:1099\u20131109","journal-title":"Adv Drug Deliv Rev"},{"key":"53_CR133","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/1520-6017(200011)89:11<1452::AID-JPS8>3.0.CO;2-P","volume":"89","author":"B Stella","year":"2000","unstructured":"Stella B, Arpicco S, Peracchia MT, Desma\u00eble D, Hoebeke J, Renoir M, D\u2019Angelo J, Cattel L, Couvreur P (2000) Design of folic acid-conjugated nanoparticles for drug targeting. J Pharm Sci 89:1452\u20131464","journal-title":"J Pharm Sci"},{"key":"53_CR134","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0005-2736(94)00235-H","volume":"1233","author":"RJ Lee","year":"1995","unstructured":"Lee RJ, Low PS (1995) Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim Biophys Acta 1233:134\u2013144","journal-title":"Biochim Biophys Acta"},{"key":"53_CR135","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.addr.2004.01.011","volume":"56","author":"A Gabizon","year":"2004","unstructured":"Gabizon A, Shmeeda H, Horowitz AT, Zalipsky S (2004) Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates. Adv Drug Deliv Rev 56:1177\u20131192","journal-title":"Adv Drug Deliv Rev"},{"key":"53_CR136","doi-asserted-by":"crossref","first-page":"8852","DOI":"10.1021\/la0502084","volume":"21","author":"SH Kim","year":"2005","unstructured":"Kim SH, Jeong JH, Chun KW, Park TG (2005) Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate. Langmuir 21:8852\u20138857","journal-title":"Langmuir"},{"key":"53_CR137","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jconrel.2004.12.018","volume":"103","author":"ES Lee","year":"2005","unstructured":"Lee ES, Na K, Bae YH (2005) Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. J Control Release 103:405\u2013418","journal-title":"J Control Release"},{"key":"53_CR138","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1124\/pr.54.4.561","volume":"54","author":"ZM Qian","year":"2002","unstructured":"Qian ZM, Li H, Sun H, Ho K (2002) Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev 54:561\u2013587","journal-title":"Pharmacol Rev"},{"key":"53_CR139","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1021\/mp050032z","volume":"2","author":"SK Sahoo","year":"2005","unstructured":"Sahoo SK, Labhasetwar V (2005) Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol Pharm 2:373\u2013383","journal-title":"Mol Pharm"},{"key":"53_CR140","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijpharm.2004.10.009","volume":"288","author":"Z Xu","year":"2005","unstructured":"Xu Z, Gu W, Huang J, Sui H, Zhou Z, Yang Y, Yan Z, Li Y (2005) In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery. Int J Pharm 288:361\u2013368","journal-title":"Int J Pharm"},{"key":"53_CR141","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0022-3565(24)36946-0","volume":"282","author":"J Huwyler","year":"1997","unstructured":"Huwyler J, Yang J, Pardridge WM (1997) Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat. J Pharmacol Exp Ther 282:1541\u20131546","journal-title":"J Pharmacol Exp Ther"},{"key":"53_CR142","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/10611860008997919","volume":"8","author":"A Cerletti","year":"2000","unstructured":"Cerletti A, Drewe J, Fricker G, Eberle AN, Huwyler J (2000) Endocytosis and transcytosis of an immunoliposome-based brain drug delivery system. J Drug Target 8:435\u2013446","journal-title":"J Drug Target"},{"key":"53_CR143","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0022-3565(24)35388-1","volume":"292","author":"HJ Lee","year":"2000","unstructured":"Lee HJ, Engelhardt B, Lesley J, Bickel U, Pardridge WM (2000) Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood\u2013brain barrier in mouse. J Pharmacol Exp Ther 292:1048\u20131052","journal-title":"J Pharmacol Exp Ther"},{"key":"53_CR144","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0014-5793(97)00905-8","volume":"413","author":"K Maruyama","year":"1997","unstructured":"Maruyama K, Takahashi N, Tagawa T, Nagaike K, Iwatsuru M (1997) Immunoliposomes bearing polyethyleneglycol-coupled Fab\u2019 fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo. FEBS Lett 413:177\u2013180","journal-title":"FEBS Lett"},{"key":"53_CR145","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1021\/bc050217o","volume":"16","author":"Y Akta\u015f","year":"2005","unstructured":"Akta\u015f Y, Yemisci M, Andrieux K, G\u00fcrsoy RN, Alonso MJ, Fernandez-Megia E, Novoa-Carballal R, Qui\u00f1o\u00e1 E, Riguera R, Sargon MF, Celik HH, Demir AS, Hincal AA, Dalkara T, Capan Y, Couvreur P (2005) Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26. Bioconjug Chem 16:1503\u20131511","journal-title":"Bioconjug Chem"},{"key":"53_CR146","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0168-3659(03)00240-2","volume":"91","author":"RM Schiffelers","year":"2003","unstructured":"Schiffelers RM, Koning GA, ten Hagen TLM, Fens MHAM, Schraa AJ, Janssen APCA, Kok RJ, Molema G, Storm G (2003) Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin. J Control Release 91:115\u2013122","journal-title":"J Control Release"},{"key":"53_CR147","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1124\/jpet.105.098970","volume":"317","author":"S Muro","year":"2006","unstructured":"Muro S, Dziubla T, Qiu W, Leferovich J, Cui X, Berk E, Muzykantov VR (2006) Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to intercellular adhesion molecule 1. J Pharmacol Exp Ther 317:1161\u20131169","journal-title":"J Pharmacol Exp Ther"},{"key":"53_CR148","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1242\/jcs.00367","volume":"116","author":"S Muro","year":"2003","unstructured":"Muro S, Wiewrodt R, Thomas A, Koniaris L, Albelda SM, Muzykantov VR, Koval M (2003) A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1. J Cell Sci 116:1599\u20131609","journal-title":"J Cell Sci"},{"key":"53_CR149","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ymthe.2005.07.687","volume":"13","author":"S Muro","year":"2006","unstructured":"Muro S, Schuchman EH, Muzykantov VR (2006) Lysosomal enzyme delivery by ICAM-1-targeted nanocarriers bypassing glycosylation- and clathrin-dependent endocytosis. Mol Ther 13:135\u2013141","journal-title":"Mol Ther"},{"key":"53_CR150","doi-asserted-by":"crossref","first-page":"L794","DOI":"10.1152\/ajplung.2000.278.4.L794","volume":"278","author":"M Christofidou-Solomidou","year":"2000","unstructured":"Christofidou-Solomidou M, Pietra GG, Solomides CC, Arguiris E, Harshaw D, Fitzgerald GA, Albelda SM, Muzykantov VR (2000) Immunotargeting of glucose oxidase to endothelium in vivo causes oxidative vascular injury in the lungs. Am J Physiol Lung Cell Mol Physiol 278:L794\u2013L805","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"53_CR151","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.addr.2007.10.008","volume":"60","author":"VP Torchilin","year":"2008","unstructured":"Torchilin VP (2008) Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. Adv Drug Deliv Rev 60:548\u2013558","journal-title":"Adv Drug Deliv Rev"},{"key":"53_CR152","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/74464","volume":"18","author":"M Lewin","year":"2000","unstructured":"Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R (2000) Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 18:410\u2013414","journal-title":"Nat Biotechnol"},{"key":"53_CR153","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1016\/j.bmcl.2007.02.001","volume":"17","author":"N Yagi","year":"2007","unstructured":"Yagi N, Yano Y, Hatanaka K, Yokoyama Y, Okuno H (2007) Synthesis and evaluation of a novel lipid-peptide conjugate for functionalized liposome. Bioorg Med Chem Lett 17:2590\u20132593","journal-title":"Bioorg Med Chem Lett"},{"key":"53_CR154","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jconrel.2006.12.008","volume":"118","author":"VA Sethuraman","year":"2007","unstructured":"Sethuraman VA, Bae YH (2007) TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors. J Control Release 118:216\u2013224","journal-title":"J Control Release"},{"key":"53_CR155","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jconrel.2005.09.036","volume":"109","author":"E Kleemann","year":"2005","unstructured":"Kleemann E, Neu M, Jekel N, Fink L, Schmehl T, Gessler T, Seeger W, Kissel T (2005) Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI. J Control Release 109:299\u2013316","journal-title":"J Control Release"},{"key":"53_CR156","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1021\/bc0255900","volume":"14","author":"A Nori","year":"2003","unstructured":"Nori A, Jensen KD, Tijerina M, Kopeckov\u00e1 P, Kopecek J (2003) Tat-conjugated synthetic macromolecules facilitate cytoplasmic drug delivery to human ovarian carcinoma cells. Bioconjug Chem 14:44\u201350","journal-title":"Bioconjug Chem"},{"key":"53_CR157","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1529\/biophysj.106.094318","volume":"92","author":"V Salnikov","year":"2007","unstructured":"Salnikov V, Lukyanenko Y, Frederick C, Lederer W, Lukyanenko V (2007) Probing the outer mitochondrial membrane in cardiac mitochondria with nanoparticles. Biophys J 92:1058\u20131071","journal-title":"Biophys J"},{"key":"53_CR158","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/ncb1487","volume":"8","author":"S Choi","year":"2006","unstructured":"Choi S, Huang P, Jenkins GM, Chan DC, Schiller J, Frohman MA (2006) A common lipid links Mfn-mediated mitochondrial fusion and SNARE-regulated exocytosis. Nat Cell Biol 8:1255\u20131262","journal-title":"Nat Cell Biol"},{"key":"53_CR159","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cell.2006.09.021","volume":"127","author":"S Meeusen","year":"2006","unstructured":"Meeusen S, DeVay R, Block J, Cassidy-Stone A, Wayson S, McCaffery JM, Nunnari J (2006) Mitochondrial inner-membrane fusion and crista maintenance requires the dynamin-related GTPase Mgm1. Cell 127:383\u2013395","journal-title":"Cell"},{"key":"53_CR160","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1021\/ja0296935","volume":"125","author":"AG Tkachenko","year":"2003","unstructured":"Tkachenko AG, Xie H, Coleman D, Glomm W, Ryan J, Anderson MF, Franzen S, Feldheim DL (2003) Multifunctional gold nanoparticle-peptide complexes for nuclear targeting. J Am Chem Soc 125:4700\u20134701","journal-title":"J Am Chem Soc"},{"key":"53_CR161","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1021\/bc050033+","volume":"16","author":"JM Fuente de la","year":"2005","unstructured":"de la Fuente JM, Berry CC (2005) Tat peptide as an efficient molecule to translocate gold nanoparticles into the cell nucleus. Bioconjug Chem 16:1176\u20131180","journal-title":"Bioconjug Chem"},{"key":"53_CR162","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1021\/nl0479987","volume":"5","author":"ES Lee","year":"2005","unstructured":"Lee ES, Na K, Bae YH (2005) Super pH-sensitive multifunctional polymeric micelle. Nano Lett 5:325\u2013329","journal-title":"Nano Lett"},{"key":"53_CR163","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1080\/10611860701498203","volume":"15","author":"AA Kale","year":"2007","unstructured":"Kale AA, Torchilin VP (2007) Enhanced transfection of tumor cells in vivo using \u201cSmart\u201d pH-sensitive TAT-modified pegylated liposomes. J Drug Target 15:538\u2013545","journal-title":"J Drug Target"},{"key":"53_CR164","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1021\/nl052396o","volume":"6","author":"B Devika Chithrani","year":"2006","unstructured":"Devika Chithrani B, Ghazani A, Chan W (2006) Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6:662\u2013668","journal-title":"Nano Lett"},{"key":"53_CR165","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/mt.2008.127","volume":"16","author":"S Muro","year":"2008","unstructured":"Muro S, Garnacho C, Champion JA, Leferovich J, Gajewski C, Schuchman EH, Mitragotri S, Muzykantov VR (2008) Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol Ther 16:1450\u20131458","journal-title":"Mol Ther"},{"key":"53_CR166","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.1073\/pnas.0801763105","volume":"105","author":"SEA Gratton","year":"2008","unstructured":"Gratton SEA, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, Napier ME, DeSimone JM (2008) The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci USA 105:11613\u201311618","journal-title":"Proc Natl Acad Sci USA"},{"key":"53_CR167","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s11095-008-9654-8","volume":"25","author":"SEA Gratton","year":"2008","unstructured":"Gratton SEA, Napier ME, Ropp PA, Tian S, Desimone JM (2008) Microfabricated particles for engineered drug therapies: elucidation into the mechanisms of cellular internalization of print particles. Pharm Res 25:2845\u20132852","journal-title":"Pharm Res"},{"key":"53_CR168","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jconrel.2008.05.021","volume":"130","author":"ZP Xu","year":"2008","unstructured":"Xu ZP, Niebert M, Porazik K, Walker TL, Cooper HM, Middelberg APJ, Gray PP, Bartlett PF, Lu GQM (2008) Subcellular compartment targeting of layered double hydroxide nanoparticles. J Control Release 130:86\u201394","journal-title":"J Control Release"},{"key":"53_CR169","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1200\/JCO.2001.19.14.3312","volume":"19","author":"AN Gordon","year":"2001","unstructured":"Gordon AN, Fleagle JT, Guthrie D, Parkin DE, Gore ME, Lacave AJ (2001) Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan. J Clin Oncol 19:3312\u20133322","journal-title":"J Clin Oncol"},{"key":"53_CR170","first-page":"95","volume":"133","author":"HF Dvorak","year":"1988","unstructured":"Dvorak HF, Nagy JA, Dvorak JT, Dvorak AM (1988) Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 133:95\u2013109","journal-title":"Am J Pathol"},{"key":"53_CR171","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ijc.20048","volume":"109","author":"SC Steiniger","year":"2004","unstructured":"Steiniger SC, Kreuter J, Khalansky AS, Skidan IN, Bobruskin AI, Smirnova ZS, Severin SE, Uhl R, Kock M, Geiger KD, Gelperina SE (2004) Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles. Int J Cancer 109:759\u2013767","journal-title":"Int J Cancer"},{"key":"53_CR172","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1023\/A:1022656105022","volume":"20","author":"XQ Pan","year":"2003","unstructured":"Pan XQ, Wang H, Lee RJ (2003) Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model. Pharm Res 20:417\u2013422","journal-title":"Pharm Res"},{"key":"53_CR173","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1023\/A:1010960900254","volume":"18","author":"O Ishida","year":"2001","unstructured":"Ishida O, Maruyama K, Tanahashi H, Iwatsuru M, Sasaki K, Eriguchi M, Yanagie H (2001) Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo. Pharm Res 18:1042\u20131048","journal-title":"Pharm Res"},{"key":"53_CR174","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/10611860500065187","volume":"13","author":"A Nan","year":"2005","unstructured":"Nan A, Ghandehari H, Hebert C, Siavash H, Nikitakis N, Reynolds M, Sauk JJ (2005) Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck. J Drug Target 13:189\u2013197","journal-title":"J Drug Target"},{"key":"53_CR175","first-page":"7190","volume":"62","author":"P Sapra","year":"2002","unstructured":"Sapra P, Allen TM (2002) Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs. Cancer Res 62:7190\u20137194","journal-title":"Cancer Res"},{"key":"53_CR176","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0168-3659(01)00315-7","volume":"74","author":"JW Park","year":"2001","unstructured":"Park JW, Kirpotin DB, Hong K, Shalaby R, Shao Y, Nielsen UB, Marks JD, Papahadjopoulos D, Benz CC (2001) Tumor targeting using anti-her2 immunoliposomes. J Control Release 74:95\u2013113","journal-title":"J Control Release"},{"key":"53_CR177","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jconrel.2008.03.010","volume":"128","author":"H Chen","year":"2008","unstructured":"Chen H, Gao J, Lu Y, Kou G, Zhang H, Fan L, Sun Z, Guo Y, Zhong Y (2008) Preparation and characterization of PE38KDEL-loaded anti-HER2 nanoparticles for targeted cancer therapy. J Control Release 128:209\u2013216","journal-title":"J Control Release"},{"key":"53_CR178","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1073\/pnas.84.21.7413","volume":"84","author":"PL Felgner","year":"1987","unstructured":"Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, Danielsen M (1987) Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 84:7413\u20137417","journal-title":"Proc Natl Acad Sci USA"},{"key":"53_CR179","first-page":"579","volume":"82","author":"CR Dass","year":"2004","unstructured":"Dass CR (2004) Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection. J Mol Med 82:579\u2013591","journal-title":"J Mol Med"},{"key":"53_CR180","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/mthe.1999.0009","volume":"1","author":"PG Noone","year":"2000","unstructured":"Noone PG, Hohneker KW, Zhou Z, Johnson LG, Foy C, Gipson C, Jones K, Noah TL, Leigh MW, Schwartzbach C, Efthimiou J, Pearlman R, Boucher RC, Knowles MR (2000) Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis. Mol Ther 1:105\u2013114","journal-title":"Mol Ther"},{"key":"53_CR181","first-page":"2285","volume":"7","author":"AT Stopeck","year":"2001","unstructured":"Stopeck AT, Jones A, Hersh EM, Thompson JA, Finucane DM, Gutheil JC, Gonzalez R (2001) Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7\/beta2-microglobulin DNA-liposome complex, in patients with metastatic melanoma. Clin Cancer Res 7:2285\u20132291","journal-title":"Clin Cancer Res"},{"key":"53_CR182","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijpharm.2008.06.011","volume":"364","author":"E Fattal","year":"2008","unstructured":"Fattal E, Bochot A (2008) State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers. Int J Pharm 364:237\u2013248","journal-title":"Int J Pharm"},{"key":"53_CR183","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1089\/oli.1.1999.9.515","volume":"9","author":"S Dheur","year":"1999","unstructured":"Dheur S, Dias N, van Aerschot A, Herdewijn P, Bettinger T, R\u00e9my JS, H\u00e9l\u00e8ne C, Saison-Behmoaras ET (1999) Polyethylenimine but not cationic lipid improves antisense activity of 3\u2032-capped phosphodiester oligonucleotides. Antisense Nucleic Acid Drug Dev 9:515\u2013525","journal-title":"Antisense Nucleic Acid Drug Dev"},{"key":"53_CR184","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1007\/s11095-006-9009-2","volume":"23","author":"AC Grayson","year":"2006","unstructured":"Grayson AC, Doody A, Putnam D (2006) Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro. Pharm Res 23:1868\u20131876","journal-title":"Pharm Res"},{"key":"53_CR185","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1089\/hum.2006.17.751","volume":"17","author":"M Grzelinski","year":"2006","unstructured":"Grzelinski M, Urban-Klein B, Martens T, Lamszus K, Bakowsky U, H\u00f6bel S, Czubayko F, Aigner A (2006) RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts. Hum Gene Ther 17:751\u2013766","journal-title":"Hum Gene Ther"},{"key":"53_CR186","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/sj.gt.3302425","volume":"12","author":"B Urban-Klein","year":"2005","unstructured":"Urban-Klein B, Werth S, Abuharbeid S, Czubayko F, Aigner A (2005) RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther 12:461\u2013466","journal-title":"Gene Ther"},{"key":"53_CR187","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.juro.2008.08.006","volume":"180","author":"AA Sidi","year":"2008","unstructured":"Sidi AA, Ohana P, Benjamin S, Shalev M, Ransom JH, Lamm D, Hochberg A, Leibovitch I (2008) Phase I\/II marker lesion study of intravesical BC-819 DNA plasmid in H19 over expressing superficial bladder cancer refractory to bacillus Calmette-Guerin. J Urol 180:2379\u20132383","journal-title":"J Urol"},{"key":"53_CR188","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1093\/nar\/gnh140","volume":"32","author":"RM Schiffelers","year":"2004","unstructured":"Schiffelers RM, Ansari A, Xu J, Zhou Q, Tang Q, Storm G, Molema G, Lu PY, Scaria PV, Woodle MC (2004) Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucl Acids Res 32:e149","journal-title":"Nucl Acids Res"},{"key":"53_CR189","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1023\/A:1015871809313","volume":"9","author":"C Chavany","year":"1992","unstructured":"Chavany C, Le Doan T, Couvreur P, Puisieux F, H\u00e9l\u00e8ne C (1992) Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides. Pharm Res 9:441\u2013449","journal-title":"Pharm Res"},{"key":"53_CR190","doi-asserted-by":"crossref","first-page":"10460","DOI":"10.1073\/pnas.91.22.10460","volume":"91","author":"G Schwab","year":"1994","unstructured":"Schwab G, Chavany C, Duroux I, Goubin G, Lebeau J, H\u00e9l\u00e8ne C, Saison-Behmoaras T (1994) Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice. Proc Natl Acad Sci USA 91:10460\u201310464","journal-title":"Proc Natl Acad Sci USA"},{"key":"53_CR191","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1093\/nar\/gkm1094","volume":"36","author":"H Martimprey de","year":"2008","unstructured":"de Martimprey H, Bertrand J, Fusco A, Santoro M, Couvreur P, Vauthier C, Malvy C (2008) siRNA nanoformulation against the Ret\/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma. Nucleic Acids Res 36:e2","journal-title":"Nucleic Acids Res"},{"key":"53_CR192","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1023\/A:1014861900478","volume":"16","author":"D Fischer","year":"1999","unstructured":"Fischer D, Bieber T, Li Y, Els\u00e4sser HP, Kissel T (1999) A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res 16:1273\u20131279","journal-title":"Pharm Res"},{"key":"53_CR193","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0300-9084(99)80002-9","volume":"80","author":"G Lambert","year":"1998","unstructured":"Lambert G, Fattal E, Brehier A, Feger J, Couvreur P (1998) Effect of polyisobutylcyanoacrylate nanoparticles and lipofectin loaded with oligonucleotides on cell viability and PKC alpha neosynthesis in HepG2 cells. Biochimie 80:969\u2013976","journal-title":"Biochimie"},{"key":"53_CR194","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1023\/A:1007582332491","volume":"17","author":"G Lambert","year":"2000","unstructured":"Lambert G, Fattal E, Pinto-Alphandary H, Gulik A, Couvreur P (2000) Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides. Pharm Res 17:707\u2013714","journal-title":"Pharm Res"},{"key":"53_CR195","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/s11095-006-9901-9","volume":"23","author":"N Toub","year":"2006","unstructured":"Toub N, Bertrand J, Tamaddon A, Elhamess H, Hillaireau H, Maksimenko A, Maccario J, Malvy C, Fattal E, Couvreur P (2006) Efficacy of siRNA nanocapsules targeted against the EWS-Fli1 oncogene in Ewing sarcoma. Pharm Res 23:892\u2013900","journal-title":"Pharm Res"},{"key":"53_CR196","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jconrel.2005.03.029","volume":"106","author":"N Toub","year":"2005","unstructured":"Toub N, Angiari C, Ebou\u00e9 D, Fattal E, Tenu J, Le Doan T, Couvreur P (2005) Cellular fate of oligonucleotides when delivered by nanocapsules of poly(isobutylcyanoacrylate). J Control Release 106:209\u2013213","journal-title":"J Control Release"},{"key":"53_CR197","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1006\/bbrc.2000.3963","volume":"279","author":"G Lambert","year":"2000","unstructured":"Lambert G, Bertrand JR, Fattal E, Subra F, Pinto-Alphandary H, Malvy C, Auclair C, Couvreur P (2000) EWS fli-1 antisense nanocapsules inhibits ewing sarcoma-related tumor in mice. Biochem Biophys Res Commun 279:401\u2013406","journal-title":"Biochem Biophys Res Commun"},{"key":"53_CR198","first-page":"1","volume":"2","author":"JF Woodley","year":"1985","unstructured":"Woodley JF (1985) Liposomes for oral administration of drugs. Crit Rev Ther Drug Carrier Syst 2:1\u201318","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"53_CR199","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1768-322X.1987.tb00571.x","volume":"61","author":"M Aprahamian","year":"1987","unstructured":"Aprahamian M, Michel C, Humbert W, Devissaguet JP, Damge C (1987) Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine. Biol Cell 61:69\u201376","journal-title":"Biol Cell"},{"key":"53_CR200","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2337\/diab.37.2.246","volume":"37","author":"C Damg\u00e9","year":"1988","unstructured":"Damg\u00e9 C, Michel C, Aprahamian M, Couvreur P (1988) New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes 37:246\u2013251","journal-title":"Diabetes"},{"key":"53_CR201","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1023\/A:1024470508758","volume":"20","author":"H Pinto-Alphandary","year":"2003","unstructured":"Pinto-Alphandary H, Aboubakar M, Jaillard D, Couvreur P, Vauthier C (2003) Visualization of insulin-loaded nanocapsules: in vitro and in vivo studies after oral administration to rats. Pharm Res 20:1071\u20131084","journal-title":"Pharm Res"},{"key":"53_CR202","first-page":"3","volume":"8","author":"C Damge","year":"1995","unstructured":"Damge C, Hillairebuys D, Puech R, Hoeltzel A, Michel C, Ribes G (1995) Effects of orally-administered insulin nanocapsules in normal and diabetic dogs. Diabetes Nutr Metabolism 8:3\u20139","journal-title":"Diabetes Nutr Metabolism"},{"key":"53_CR203","doi-asserted-by":"crossref","unstructured":"Tob\u00edo M, S\u00e1nchez A, Vila A, Soriano I, Evora C, Vila-Jato JL, Alonso MJ (2000) The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration. Colloids Surf B Biointerfaces 18:315\u2013323","DOI":"10.1016\/S0927-7765(99)00157-5"},{"key":"53_CR204","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jconrel.2006.10.023","volume":"117","author":"C Damg\u00e9","year":"2007","unstructured":"Damg\u00e9 C, Maincent P, Ubrich N (2007) Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J Control Release 117:163\u2013170","journal-title":"J Control Release"},{"key":"53_CR205","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1023\/A:1018908705446","volume":"16","author":"R Fern\u00e1ndez-Urrusuno","year":"1999","unstructured":"Fern\u00e1ndez-Urrusuno R, Calvo P, Remu\u00f1\u00e1n-L\u00f3pez C, Vila-Jato JL, Alonso MJ (1999) Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm Res 16:1576\u20131581","journal-title":"Pharm Res"},{"key":"53_CR206","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jconrel.2004.04.026","volume":"98","author":"A Vila","year":"2004","unstructured":"Vila A, Gill H, McCallion O, Alonso MJ (2004) Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. J Control Release 98:231\u2013244","journal-title":"J Control Release"},{"key":"53_CR207","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jconrel.2004.07.030","volume":"101","author":"C Prego","year":"2005","unstructured":"Prego C, Garc\u00eda M, Torres D, Alonso MJ (2005) Transmucosal macromolecular drug delivery. J Control Release 101:151\u2013162","journal-title":"J Control Release"},{"key":"53_CR208","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tibtech.2007.09.005","volume":"25","author":"JC Sung","year":"2007","unstructured":"Sung JC, Pulliam BL, Edwards DA (2007) Nanoparticles for drug delivery to the lungs. Trends Biotechnol 25:563\u2013570","journal-title":"Trends Biotechnol"},{"key":"53_CR209","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0168-3659(99)00048-6","volume":"62","author":"Y Kawashima","year":"1999","unstructured":"Kawashima Y, Yamamoto H, Takeuchi H, Fujioka S, Hino T (1999) Pulmonary delivery of insulin with nebulized DL-lactide\/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect. J Control Release 62:279\u2013287","journal-title":"J Control Release"},{"key":"53_CR210","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0378-5173(01)00614-7","volume":"218","author":"Q Zhang","year":"2001","unstructured":"Zhang Q, Shen Z, Nagai T (2001) Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats. Int J Pharm 218:75\u201380","journal-title":"Int J Pharm"},{"key":"53_CR211","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jconrel.2004.10.010","volume":"102","author":"H Yamamoto","year":"2005","unstructured":"Yamamoto H, Kuno Y, Sugimoto S, Takeuchi H, Kawashima Y (2005) Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. J Control Release 102:373\u2013381","journal-title":"J Control Release"},{"key":"53_CR212","doi-asserted-by":"crossref","first-page":"12001","DOI":"10.1073\/pnas.182233999","volume":"99","author":"N Tsapis","year":"2002","unstructured":"Tsapis N, Bennett D, Jackson B, Weitz DA, Edwards DA (2002) Trojan particles: large porous carriers of nanoparticles for drug delivery. Proc Natl Acad Sci USA 99:12001\u201312005","journal-title":"Proc Natl Acad Sci USA"},{"key":"53_CR213","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejps.2005.04.009","volume":"25","author":"A Grenha","year":"2005","unstructured":"Grenha A, Seijo B, Remu\u00f1\u00e1n-L\u00f3pez C (2005) Microencapsulated chitosan nanoparticles for lung protein delivery. Eur J Pharm Sci 25:427\u2013437","journal-title":"Eur J Pharm Sci"},{"key":"53_CR214","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejps.2007.02.008","volume":"31","author":"A Grenha","year":"2007","unstructured":"Grenha A, Grainger CI, Dailey LA, Seijo B, Martin GP, Remu\u00f1\u00e1n-L\u00f3pez C, Forbes B (2007) Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro. Eur J Pharm Sci 31:73\u201384","journal-title":"Eur J Pharm Sci"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-009-0053-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-009-0053-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-009-0053-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T05:43:59Z","timestamp":1739166239000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-009-0053-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,5]]},"references-count":214,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["53"],"URL":"https:\/\/doi.org\/10.1007\/s00018-009-0053-z","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,5]]}}}